Latest Decheng Capital Management III (Cayman), LLC Stock Portfolio
$299Million
About Decheng Capital Management III (Cayman), LLC and 13F Hedge Fund Stock Holdings
On 2023-12-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, Decheng Capital Management III (Cayman), LLC reported an equity portfolio of $299.6 Millions as of 30 Sep, 2023. <br><br> The top stock holdings of Decheng Capital Management III (Cayman), LLC are ALPN, ZNTL, AURA. The fund has invested 25.6% of it's portfolio in ALPINE IMMUNE SCIENCES, INC. and 14.1% of portfolio in ZENTALIS PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off ALPINE IMMUNE SCIENCES, INC., SEAGEN INC. (SGEN) and GENEDX HOLDINGS CORP. (SMFR) stocks. They significantly reduced their stock positions in ADICET BIO, INC. (ACET) and ACELYRIN INC(NSM). Decheng Capital Management III (Cayman), LLC opened new stock positions in ALPINE IMMUNE SCIENCES, INC. (ALPN), ROIVANT SCIENCES LTD (ROIV) and LANTHEUS HOLDINGS INC(NMS) (LNTH). The fund showed a lot of confidence in some stocks as they added substantially to AURA BIOSCIENCES, INC. (AURA).
Decheng Capital Management III (Cayman), LLC Equity Portfolio Value
Last Reported on: 12 Dec, 2023
$299Million
as of Dec 12, 2023New Buys
| Ticker | $ Bought |
|---|---|
| alpine immune sciences, inc. | 76,809,900 |
| roivant sciences ltd | 17,049,300 |
| lantheus holdings inc(nms) | 9,879,780 |
| immunogen inc | 6,600,020 |
| seagen inc | 4,882,420 |
| beyondspring inc. | 3,966,510 |
| atricure inc. | 2,026,140 |
| pyxis oncology, inc (formerly apexigen) | 650,352 |
New stocks bought by Decheng Capital Management III (Cayman), LLC
Additions
| Ticker | % Inc. |
|---|---|
| aura biosciences, inc. | 296 |
Additions to existing portfolio by Decheng Capital Management III (Cayman), LLC
Reductions
| Ticker | % Reduced |
|---|---|
| adicet bio, inc. | -60.41 |
| acelyrin inc(nsm) | -0.39 |
Decheng Capital Management III (Cayman), LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| alpine immune sciences, inc. | -68,961,200 |
| beyondspring inc. | -5,850,610 |
| apexigen, inc. | -814,278 |
| roivant sciences ltd | -14,713,800 |
| genedx holdings corp. | -617,479 |
| neubase therapeutics, inc. | -92,500 |
| atricure inc. | -2,283,340 |
| seagen inc. | -4,429,270 |
Decheng Capital Management III (Cayman), LLC got rid off the above stocks
Decheng Capital Management III (Cayman), LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Decheng Capital Management III (Cayman), LLC
$299.64MTotal Value
34.00Positions
12 Dec, 2023Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aadi Bioscience, Inc. Decheng Capital Management III (Cayman), LLC's holding in Aadi Bioscience, Inc. over time | 0.85% | 526,329 | $2.55M 0.85% | 0%unchanged 0 percentunchanged | |
 Adicet Bio, Inc. Adicet Bio, Inc.ACET Decheng Capital Management III (Cayman), LLC's holding in Adicet Bio, Inc. over time | 0.09% | 200,201 | $274.3K 0.09% | 60.41%decreased 60.41 percentreduced | |
 Alpine Immune Sciences, Inc. Decheng Capital Management III (Cayman), LLC's holding in Alpine Immune Sciences, Inc. over time | 25.63% | 6,708,290 | $76.81M 25.63% | Newnew position | |
 Atricure Inc. Atricure Inc.ATRC Decheng Capital Management III (Cayman), LLC's holding in Atricure Inc. over time | 0.68% | 46,259 | $2.03M 0.68% | Newnew position | |
 Aura Biosciences, Inc. Decheng Capital Management III (Cayman), LLC's holding in Aura Biosciences, Inc. over time | 6.09% | 1,163,120 | $18.24M 6.09% | 296.52%increased 296.52 percentadded | |
 Equillium Inc. Decheng Capital Management III (Cayman), LLC's holding in Equillium Inc. over time | 1.1% | 4,447,310 | $3.29M 1.1% | 0%unchanged 0 percentunchanged | |
 Cue Health Inc. Cue Health Inc.HLTH Decheng Capital Management III (Cayman), LLC's holding in Cue Health Inc. over time | 1.32% | 8,980,910 | $3.97M 1.32% | 0%unchanged 0 percentunchanged | |
 Horizon Therapeutics Plc Decheng Capital Management III (Cayman), LLC's holding in Horizon Therapeutics Plc over time | 3.05% | 78,900 | $9.13M 3.05% | 0%unchanged 0 percentunchanged | |
 Illumnia, Inc. Illumnia, Inc.ILMN Decheng Capital Management III (Cayman), LLC's holding in Illumnia, Inc. over time | 3.7% | 80,859 | $11.10M 3.7% | 0%unchanged 0 percentunchanged | |
 Immunogen Inc Immunogen IncIMGN Decheng Capital Management III (Cayman), LLC's holding in Immunogen Inc over time | 2.2% | 415,880 | $6.60M 2.2% | Newnew position | |
 Lantheus Holdings Inc(Nms) Decheng Capital Management III (Cayman), LLC's holding in Lantheus Holdings Inc(Nms) over time | 3.3% | 142,196 | $9.88M 3.3% | Newnew position | |
 Mersana Therapeutics, Inc. Decheng Capital Management III (Cayman), LLC's holding in Mersana Therapeutics, Inc. over time | 0.38% | 904,268 | $1.15M 0.38% | 0%unchanged 0 percentunchanged | |
 Neubase Therapeutics, Inc. Decheng Capital Management III (Cayman), LLC's holding in Neubase Therapeutics, Inc. over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Pacific Biosciences Of California, Inc. Decheng Capital Management III (Cayman), LLC's holding in Pacific Biosciences Of California, Inc. over time | 4.08% | 1,463,870 | $12.22M 4.08% | 0%unchanged 0 percentunchanged | |
 Phathom Pharmaceuticals Inc Decheng Capital Management III (Cayman), LLC's holding in Phathom Pharmaceuticals Inc over time | 2.94% | 850,000 | $8.81M 2.94% | 0%unchanged 0 percentunchanged | |
 Pyxis Oncology, Inc (Formerly Apexigen) Decheng Capital Management III (Cayman), LLC's holding in Pyxis Oncology, Inc (Formerly Apexigen) over time | 0.22% | 326,810 | $650.4K 0.22% | Newnew position | |
 Arcus Biosciences, Inc Decheng Capital Management III (Cayman), LLC's holding in Arcus Biosciences, Inc over time | 5.21% | 869,790 | $15.61M 5.21% | 0%unchanged 0 percentunchanged | |
 Roivant Sciences Ltd Decheng Capital Management III (Cayman), LLC's holding in Roivant Sciences Ltd over time | 5.69% | 1,459,700 | $17.05M 5.69% | Newnew position | |
 Scynexis Inc. Scynexis Inc.SCYX Decheng Capital Management III (Cayman), LLC's holding in Scynexis Inc. over time | 0.42% | 555,555 | $1.27M 0.42% | 0%unchanged 0 percentunchanged | |
 Seagen Inc Seagen IncSGEN Decheng Capital Management III (Cayman), LLC's holding in Seagen Inc over time | 1.63% | 23,014 | $4.88M 1.63% | Newnew position | |